Truncation of type IV pilin induces mucoidy in Pseudomonas aeruginosa strain PAO579

MicrobiologyOpen

Volumn 2, Issue 3, 2013, Pages 459-470

  Ryan Withers, T ^a   Heath Damron, F ^a,c   Yin, Yeshi ^a   Yu, Hongwei D ^a,b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Progenesis Technologies   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alginate; Biofilms; muc 23; pilA; Pseudomonas aeruginosa

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; PHENYLALANYLTHREONYLPHENYLALANINE; PILIN; PILIN TYPE IV; PROTEIN ALGU; PROTEIN ALGW; PROTEIN MUCP; SIGMA FACTOR RPON; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL PHENOMENA AND FUNCTIONS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INACTIVATION; GENE SEQUENCE; MUCOIDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PILA GENE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; RPON GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; WESTERN BLOTTING;

ALGINATES; DNA MUTATIONAL ANALYSIS; FIMBRIAE PROTEINS; GENE KNOCKOUT TECHNIQUES; GENOME, BACTERIAL; GLUCURONIC ACID; HEXURONIC ACIDS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PILA; PSEUDOMONAS AERUGINOSA;

EID: 84895501913     PISSN: None     EISSN: 20458827     Source Type: Journal    
DOI: 10.1002/mbo3.86     Document Type: Article

References (40)

1. Anthony, M., B. Rose, M. B. Pegler, M. Elkins, H. Service, K. Thamotharampillai, et al. 2002. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol. 40:2772-2778.
2. Bauernfeind, A., R. M. Bertele, K. Harms, G. Horl, R. Jungwirth, C. Petermuller, et al. 1987. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 15:270-277.
3. Boucher, J. C., H. Yu, M. H. Mudd, and V. Deretic . 1997. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun. 65:3838-3846.
4. Boucher, J. C., M. J. Schurr, and V. Deretic . 2000. Dual regulation of mucoidy in Pseudomonas aeruginosa and sigma factor antagonism. Mol. Microbiol. 36:341-351.
5. Cezairliyan, B. O., and R. T. Sauer . 2009. Control of Pseudomonas aeruginosa AlgW protease cleavage of MucA by peptide signals and MucB. Mol. Microbiol. 72:368-379.
6. Chmiel, J. F., and P. B. Davis . 2003. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir. Res. 4:8.
7. Damron, F. H., D. Qiu, and H. D. Yu . 2009. The Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate production through AlgW-dependent MucA proteolysis. J. Bacteriol. 191:2285-2295.
8. Damron, F. H., J. P. Owings, Y. Okkotsu, J. J. Varga, J. R. Schurr, J. B. Goldberg, et al. 2012. Analysis of the Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and sigma factor RpoN. J. Bacteriol. 194:1317-1330.
9. Dasgupta, N., M. C. Wolfgang, A. L. Goodman, S. K. Arora, J. Jyot, S. Lory, et al. 2003. A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol. Microbiol. 50:809-824.
10. Doig, P., T. Todd, P. A. Sastry, K. K. Lee, R. S. Hodges, W. Paranchych, et al. 1988. Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect. Immun. 56:1641-1646.
11. Figurski, D. H., and D. R. Helinski . 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl Acad. Sci. USA 76:1648-1652.
12. Govan, J. R., and V. Deretic . 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
13. Govan, J. R., and J. A. Fyfe . 1978. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J. Antimicrob. Chemother. 4:233-240.
14. Graupner, S., and W. Wackernagel . 2000. A broad-host-range expression vector series including a Ptac test plasmid and its application in the expression of the dod gene of Serratia marcescens (coding for ribulose-5-phosphate 3-epimerase) in Pseudomonas stutzeri. Biomol. Eng. 17:11-16.
15. Henry, R. L., C. M. Mellis, and L. Petrovic . 1992. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol. 12:158-161.
16. Hoang, T. T., A. J. Kutchma, A. Becher, and H. P. Schweizer . 2000. Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43:59-72.
17. Hobbs, M., E. S. Collie, P. D. Free, S. P. Livingston, and J. S. Mattick . 1993. PilS and PilR, a two-component transcriptional regulatory system controlling expression of type 4 fimbriae in Pseudomonas aeruginosa. Mol. Microbiol. 7:669-682.
18. Knutson, C. A., and A. Jeanes . 1968. A new modification of the carbazole reaction: application to heteropolysaccharides. Anal. Biochem. 24:470-481.
19. Kus, J. V., E. Tullis, D. G. Cvitkovitch, and L. L. Burrows . 2004. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150:1315-1326.
20. Leid, J. G., C. J. Willson, M. E. Shirtliff, D. J. Hassett, M. R. Parsek, and A. K. Jeffers . 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512-7518.
21. Lyczak, J. B., C. L. Cannon, and G. B. Pier . 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
22. Martin, D. W., M. J. Schurr, M. H. Mudd, J. R. Govan, B. W. Holloway, and V. Deretic . 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl Acad. Sci. USA 90:8377-8381.
23. Mattick, J. S. 2002. Type IV pili and twitching motility. Annu. Rev. Microbiol. 56:289-314.
24. Miller, J. H. 1972. Beta-galactosidase assay. Pp. 352-355 in J. H. Miller, ed. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Oliver, A., R. Canton, P. Campo, F. Baquero, and J. Blazquez . 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254.
26. Oliver, A., F. Baquero, and J. Blazquez . 2002. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol. 43:1641-1650.
27. Preston, M. J., P. C. Seed, D. S. Toder, B. H. Iglewski, D. E. Ohman, J. K. Gustin, et al. 1997. Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. Infect. Immun. 65:3086-3090.
28. Qiu, D., V. M. Eisinger, D. W. Rowen, and H. D. Yu . 2007. Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 104:8107-8112.
29. Qiu, D., F. H. Damron, T. Mima, H. P. Schweizer, and H. D. Yu . 2008a. PBAD-based shuttle vectors for functional analysis of toxic and highly-regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl. Environ. Microbiol. 74:7422-7426.
30. Qiu, D., V. M. Eisinger, N. E. Head, G. B. Pier, and H. D. Yu . 2008b. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology 154:2119-2130.
31. Rommens, J. M., M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer, M. Dean, et al. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065.
32. Saiman, L., G. Cacalano, D. Gruenert, and A. Prince . 1992. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect. Immun. 60:2808-2814.
33. Sambrook, J., and D. Russell . 2001. P. 2344 in Molecular cloning a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
34. Schurr, M. J., H. Yu, J. M. Martinez-Salazar, J. C. Boucher, and V. Deretic . 1996. Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J. Bacteriol. 178:4997-5004.
35. Stanisich, V., and B. Holloway . 1969. Conjugation in Pseudomonas aeruginosaGenetics 61:327-339.
36. Withers, T. R., S. L. Johnson, and H. D. Yu . 2012. Draft genome sequence for Pseudomonas aeruginosa strain PAO579, a mucoid derivative of PAO381. J. Bacteriol. 194:6617.
37. Wood, L. F., and D. E. Ohman . 2009. Use of cell wall stress to characterize sigma 22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa. Mol. Microbiol. 72:183-201.
38. Wood, L. F., A. J. Leech, and D. E. Ohman . 2006. Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: roles of sigma (AlgT) and the AlgW and Prc proteases. Mol. Microbiol. 62:412-426.
39. Wozniak, D. J., and D. E. Ohman . 1994. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J. Bacteriol. 176:6007-6014.
40. Yang, Z., R. Lux, W. Hu, C. Hu, and W. Shi . 2010. PilA localization affects extracellular polysaccharide production and fruiting body formation in Myxococcus xanthus. Mol. Microbiol. 76:1500-1513.